LOXO: Oncology drugs gains FDA breakthrough status

Loxo Oncology known to develop oncological drugs and cancer treatments have developed a drug Loxo-292 drug to combat certain types of lung and thyroid cancers. This drug has attained FDA approval and in the upcoming years, the company plans to update on Loxo-292 drug’s long-term clinical plan based on global regulators.

Link: https://www.stamfordadvocate.com/business/article/Loxo-Oncology-drug-gains-FDA-Breakthrough-status-13209791.php